Genenta Science (GNTA)

• Market cap: $39.4M
• 1 day: -0.6%
• 5 days: -9.24%
• 1 month: -7.22%
• 3 months: 141.12%
• 6 months: 18.44%
• Year to date: 18.44%
• 1 year: -58.04%
• 5 years: -84.82%
• 10 years: -84.82%
• Sector: Healthcare
• Industry: Biotechnology

About: Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon, a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

Employees: 9